Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000899243-18-015771

Options or other derivatives

  • Director acquired 17,783 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bronstein Ben Director 2018-06-07 Grant or award · Employee Stock Option (Right to Buy) +15,526 15,526 D
Bronstein Ben Director 2018-06-07 Grant or award · Employee Stock Option (Right to Buy) +1,354 1,354 D
Bronstein Ben Director 2018-06-07 Grant or award · Employee Stock Option (Right to Buy) +903 903 D
Loading xslF345X03/doc4.xml…